Activities of daily living as an outcome measure in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

被引:0
|
作者
Gauthier, S
Bodick, N
Erzigkeit, E
Feldman, H
Geldmacher, DS
Huff, J
Mohs, R
Orgogozo, JM
Rogers, S
机构
[1] ELI LILLY & CO, CNS DISCOVERY MED, ELI LILLY & CO, INDIANAPOLIS, IN 46285 USA
[2] UNIV ERLANGEN NURNBERG, PSYCHIAT CLIN POLYCLIN, D-8520 ERLANGEN, GERMANY
[3] UNIV BRITISH COLUMBIA, VANCOUVER GEN HOSP, VANCOUVER, BC V5Z 1M9, CANADA
[4] UNIV BRITISH COLUMBIA, HLTH SCI CTR, VANCOUVER, BC V5Z 1M9, CANADA
[5] UNIV HOSP CLEVELAND, RUSH ALZHEIMERS DIS CTR, CLEVELAND, OH 44106 USA
[6] HOECHST MARION ROUSSEL INC, BRIDGEWATER, NJ USA
[7] VET AFFAIRS MED CTR, MT SINAI SCH MED, DEPT PSYCHIAT, NEW YORK, NY USA
[8] HOSP PELLEGRIN, DEPT NEUROL, BORDEAUX, FRANCE
[9] EISAI AMER INC, CLIN RES, TEANECK, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:6 / 7
页数:2
相关论文
共 26 条
  • [1] Length of clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Levy, R
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 33 - 33
  • [2] Translation issues in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Feldman, H
    Anand, R
    Blesa, R
    Dubois, B
    Gray, J
    Homma, A
    Mohr, E
    Morris, JC
    Parys, W
    Raschig, A
    Robillard, A
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 61 - 64
  • [3] Objective psychometric tests in clinical trials of dementia drugs - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Ferris, SH
    Lucca, U
    Mohs, R
    Dubois, B
    Wesnes, K
    Erzigkeit, H
    Geldmacher, D
    Bodick, N
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 34 - 38
  • [4] Diagnostic criteria for dementia in clinical trials - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Antuono, P
    Doody, R
    Gilman, S
    Huff, J
    Scheltens, P
    Ueda, K
    Khachaturian, ZS
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 22 - 25
  • [5] Clinical trials of treatment for noncognitive symptoms of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Homma, A
    Brodaty, H
    Bruno, G
    Cummings, JL
    Gilman, S
    Gracon, S
    McKeith, IG
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 54 - 55
  • [6] Clinical global measures of dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Reisberg, B
    Schneider, L
    Doody, R
    Anand, R
    Feldman, H
    Haraguchi, H
    Kumar, R
    Lucca, U
    Mangone, CA
    Mohr, E
    Morris, JC
    Rogers, S
    Sawada, T
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 8 - 18
  • [7] Ethical issues in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Post, SG
    Beerman, B
    Brodaty, H
    Gaines, AW
    Gauthier, SG
    Geldmacher, DS
    Hill, S
    Homma, A
    Rossor, MN
    Whitehouse, PJ
    Winblad, B
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 26 - 28
  • [8] Issues in the economic evaluation of treatment for dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Winblad, B
    Hill, S
    Beermann, B
    Post, SG
    Wimo, A
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 39 - 45
  • [9] Quality-of-life assessment in dementia drug development - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Whitehouse, PJ
    Orgogozo, JM
    Becker, RE
    Gauthier, S
    Pontecorvo, M
    Erzigkeit, H
    Rogers, S
    Mohs, RC
    Bodick, N
    Bruno, G
    DalBianco, P
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 56 - 60
  • [10] Prevention protocols for Alzheimer disease - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Thal, LJ
    Carta, A
    Doody, R
    Leber, P
    Mohs, R
    Schneider, L
    Shimohama, S
    Silber, C
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 46 - 49